 |
 |

Detection of Clinically Amelanotic Malignant Melanoma and Assessment of Its Margins by In Vivo Confocal Scanning Laser Microscopy
Klaus J. Busam, MD;
Katherine Hester, MD;
Carlos Charles, MD;
Dana L. Sachs, MD;
Cristina R. Antonescu, MD;
Salvador Gonzalez, MD;
Allan C. Halpern, MD
Arch Dermatol. 2001;137:923-929.
Background Near-infrared confocal scanning laser microscopy (CSLM) represents a novel imaging technique for in vivo microscopic analysis of skin lesions, including pigmented lesions.
Objectives To investigate the feasibility of detecting a clinically amelanotic malignant cutaneous melanoma using CSLM and to explore the use of this technique for assessing its margins.
Patients and Methods Two lesions from 2 patients were imaged and analyzed using CSLM. Sites suspected to represent melanoma or benign skin on CSLM were marked as such; then, biopsy specimens were obtained for diagnosis using conventional histological analysis. Both lesions were stained for melanin pigment and analyzed immunohistochemically for the expression of melanosomal markers. In 1 case, a biopsy specimen was also examined with electron microscopy.
Results The images obtained using CSLM allowed recognition of an abnormal intraepidermal melanocytic proliferation that was distinctly different from normal skin. Comparison of the sites examined using CSLM and subsequently using conventional histological methods revealed that CSLM correctly identified intraepidermal melanoma and benign skin. Fontana-Masson stains and immunohistochemical and ultrastructural studies showed that clinically amelanotic melanoma cells contained melanosomes and rare melanin granules.
Conclusions We demonstrated, for the first time, the detection of clinically amelanotic melanoma using CSLM. This technique may aid in the early detection of clinically barely visible or nonpigmented melanomas and may facilitate preoperative noninvasive assessment of their margins.
From the Department of Pathology (Drs Busam and Antonescu) and the Dermatology Service, Department of Medicine (Drs Hester, Charles, Sachs, and Halpern), Memorial Sloan-Kettering Cancer Center, New York, NY; and Wellman Laboratories, Massachusettes General Hospital, and the Department of Dermatology, Harvard Medical School, Boston (Dr Gonzalez).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(7):986-987.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
In Vivo Microscopic Features of Nodular Melanomas: Dermoscopy, Confocal Microscopy, and Histopathologic Correlates
Segura et al.
Arch Dermatol 2008;144:1311-1320.
ABSTRACT
| FULL TEXT
In vivo confocal microscopy of Meissner corpuscles as a measure of sensory neuropathy
Herrmann et al.
Neurology 2007;69:2121-2127.
ABSTRACT
| FULL TEXT
Microscopic In Vivo Description of Cellular Architecture of Dermoscopic Pigment Network in Nevi and Melanomas
Pellacani et al.
Arch Dermatol 2005;141:147-154.
ABSTRACT
| FULL TEXT
Confocal Scanning Laser Reflectance Microscopy: Why Bother?
Marghoob and Halpern
Arch Dermatol 2005;141:212-215.
FULL TEXT
Use of In Vivo Confocal Microscopy in Malignant Melanoma: An Aid in Diagnosis and Assessment of Surgical and Nonsurgical Therapeutic Approaches
Curiel-Lewandrowski et al.
Arch Dermatol 2004;140:1127-1132.
ABSTRACT
| FULL TEXT
Nodular Lesion in a Kidney Transplant Recipient--Diagnosis
Arch Dermatol 2003;139:1209-1214.
FULL TEXT
|